Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02399254 : The Trajectory of Physical Activity Following Pulmonary Rehabilitation
Phase
AgesMin: 40 Years Max: N/A
Eligibility
Inclusion Criteria:

1. Adults (= 40 years) with a primary clinical diagnosis of COPD

2. A post-bronchodilator FEV1/FVC < 0.70 from spirometry performed within the preceding
12 months (no specific FEV1 percent-predicted requirement, although we anticipate the
FEV1 will average around 45% of predicted, based on previous studies of pulmonary
rehabilitation)

3. The patient was referred to pulmonary rehabilitation

4. The patient is clinically-stable: no exacerbation in preceding 4 weeks

5. Modified Medical Research Council (mMRC) dyspnea rating of at least 2 out of 5.

Exclusion Criteria:

1. Disease severity or co-morbidity that would make the patient be at-risk for
participation this study

2. A significant movement disorder, such as hemiplegia, etc.

3. Inability to read and comprehend the questionnaires, which will be in English

4. A history of poor wound healing or chronic skin conditions that might predispose to
local problems from wearing the DynaPort. (The DynaPort can be worn outside a thin
garment, such as a tee shirt, and is relatively thin, without protruding parts.
However, since the device may be worn overnight, and there is a remote risk of
pressure problems, this exclusion criterion was added).
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02399254      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740